HSBC Holdings’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.3M | Sell |
36,300
-77,498
| -68% | -$2.78M | ﹤0.01% | 1289 |
|
|
2025
Q1 | $3.5M | Sell |
113,798
-58,518
| -34% | -$1.8M | ﹤0.01% | 973 |
|
|
2024
Q4 | $4.38M | Sell |
172,316
-30,304
| -15% | -$770K | ﹤0.01% | 943 |
|
|
2024
Q3 | $5.69M | Sell |
202,620
-322,194
| -61% | -$9.05M | ﹤0.01% | 885 |
|
|
2024
Q2 | $13.8M | Sell |
524,814
-399,619
| -43% | -$10.5M | 0.01% | 689 |
|
|
2024
Q1 | $28.1M | Buy |
924,433
+779,163
| +536% | +$23.7M | 0.02% | 566 |
|
|
2023
Q4 | $4.06M | Buy |
145,270
+10,893
| +8% | +$305K | ﹤0.01% | 980 |
|
|
2023
Q3 | $3.63M | Buy |
134,377
+1,682
| +1% | +$45.5K | ﹤0.01% | 952 |
|
|
2023
Q2 | $4.07M | Buy |
132,695
+107,591
| +429% | +$3.3M | ﹤0.01% | 934 |
|
|
2023
Q1 | $906K | Sell |
25,104
-750,073
| -97% | -$27.1M | ﹤0.01% | 1433 |
|
|
2022
Q4 | $30.3M | Buy |
775,177
+308,651
| +66% | +$12.1M | 0.03% | 459 |
|
|
2022
Q3 | $18.9M | Buy |
466,526
+232,534
| +99% | +$9.41M | 0.03% | 504 |
|
|
2022
Q2 | $9.82M | Buy |
+233,992
| New | +$9.82M | 0.01% | 791 |
|
|
2021
Q4 | – | Sell |
-26,164
| Closed | -$956K | – | 2811 |
|
|
2021
Q3 | $956K | Buy |
26,164
+9,217
| +54% | +$337K | ﹤0.01% | 1512 |
|
|
2021
Q2 | $700K | Buy |
+16,947
| New | +$700K | ﹤0.01% | 1589 |
|
|
2021
Q1 | – | Sell |
-18,341
| Closed | -$899K | – | 2560 |
|
|
2020
Q4 | $899K | Buy |
18,341
+12,307
| +204% | +$603K | ﹤0.01% | 1397 |
|
|
2020
Q3 | $259K | Buy |
+6,034
| New | +$259K | ﹤0.01% | 1917 |
|